10X Genomics Stock Options
| TXG Stock | USD 10.29 0.22 2.09% |
10X Genomics' latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 1.37 with a put-to-call open interest ratio of 0.31 over 23 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on May 16th 2025. The total put volume is at 1.0, with calls trading at the volume of 17.0. This yields a 0.06 put-to-call volume ratio.
Open Interest Against May 16th 2025 Option Contracts
2025-05-16
The chart above shows 10X Genomics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. 10X Genomics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for 10X Genomics' option, there is no secondary market available for investors to trade.
10X Genomics Maximum Pain Price Across 2025-05-16 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as 10X Genomics close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, 10X Genomics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on 10X Genomics
Analyzing 10X Genomics' in-the-money options over time can help investors to take a profitable long position in 10X Genomics regardless of its overall volatility. This is especially true when 10X Genomics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money 10X Genomics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with 10X Genomics' stock while costing only a fraction of its price.
10X Genomics In The Money Call Balance
When 10X Genomics' strike price is surpassing the current stock price, the option contract against 10X Genomics stock is said to be in the money. When it comes to buying 10X Genomics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on 10X Genomics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
10X Current Options Market Mood
10X Genomics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps 10X Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most 10X Genomics' options investors are not very successful. 10X Genomics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current 10X contract
Base on the Rule 16, the options market is currently suggesting that 10X Genomics will have an average daily up or down price movement of about 0.0856% per day over the life of the 2025-05-16 option contract. With 10X Genomics trading at USD 10.29, that is roughly USD 0.008811. If you think that the market is fully incorporating 10X Genomics' daily price movement you should consider buying 10X Genomics options at the current volatility level of 1.37%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
10X |
Purchasing 10X Genomics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" 10X calls. Remember, the seller must deliver 10X Genomics stock to the call owner when a call is exercised.
10X Genomics Option Chain
When 10X Genomics' strike price is surpassing the current stock price, the option contract against 10X Genomics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
10X Genomics' option chain is a display of a range of information that helps investors for ways to trade options on 10X. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for 10X. It also shows strike prices and maturity days for a 10X Genomics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | TXG250516C00035000 | 31 | 35.0 | 0.0 - 0.15 | 0.08 | Out |
Call | TXG250516C00030000 | 54 | 30.0 | 0.0 - 0.25 | 0.2 | Out |
Call | TXG250516C00025000 | 91 | 25.0 | 0.0 - 0.1 | 0.1 | Out |
Call | TXG250516C00022500 | 196 | 22.5 | 0.0 - 1.25 | 0.1 | Out |
Call | TXG250516C00020000 | 1339 | 20.0 | 0.0 - 2.2 | 0.1 | Out |
Call | TXG250516C00017500 | 271 | 17.5 | 0.0 - 0.4 | 0.13 | Out |
Call | TXG250516C00015000 | 238 | 15.0 | 0.15 - 0.35 | 0.25 | Out |
Call | TXG250516C00012500 | 51 | 12.5 | 0.55 - 0.85 | 0.8 | Out |
Call | TXG250516C00010000 | 122 | 10.0 | 1.5 - 1.95 | 1.78 | In |
Call | TXG250516C00007500 | 22 | 7.5 | 2.85 - 3.8 | 3.85 | In |
Call | TXG250516C00005000 | 20 | 5.0 | 5.0 - 5.8 | 10.17 | In |
Put | TXG250516P00002500 | 1 | 2.5 | 0.0 - 0.75 | 0.21 | Out |
Put | TXG250516P00005000 | 1 | 5.0 | 0.0 - 0.75 | 0.05 | Out |
Put | TXG250516P00007500 | 101 | 7.5 | 0.15 - 0.4 | 0.3 | Out |
Put | TXG250516P00010000 | 241 | 10.0 | 0.95 - 1.4 | 1.1 | Out |
Put | TXG250516P00012500 | 270 | 12.5 | 2.4 - 2.9 | 2.35 | In |
Put | TXG250516P00015000 | 83 | 15.0 | 4.5 - 4.9 | 4.5 | In |
Put | TXG250516P00017500 | 15 | 17.5 | 6.6 - 7.6 | 7.0 | In |
Put | TXG250516P00020000 | 38 | 20.0 | 9.1 - 10.5 | 8.72 | In |
Put | TXG250516P00022500 | 3 | 22.5 | 11.2 - 14.1 | 8.05 | In |
Put | TXG250516P00025000 | 4 | 25.0 | 12.5 - 15.6 | 12.6 | In |
Put | TXG250516P00030000 | 0 | 30.0 | 18.8 - 20.3 | 18.8 | In |
Put | TXG250516P00035000 | 0 | 35.0 | 22.9 - 25.2 | 18.4 | In |
10X Genomics Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
10X Genomics Market Cap Over Time
Market Cap |
| Timeline |
10X Total Stockholder Equity
Total Stockholder Equity |
|
10X Genomics Corporate Management
| James Wilbur | Chief Officer | Profile | |
| Mennah Moustafa | Chief Officer | Profile | |
| Ruth Backer | Chief Officer | Profile | |
| Florian Baumgartner | Senior Manager | Profile | |
| Jonathan Schimmel | VP Operations | Profile | |
| Jim Goodrich | Chief Operations | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 10X Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 10X Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share | Quarterly Revenue Growth (0.10) | Return On Assets | Return On Equity |
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 10X Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.